Study: The Immune Effects of Seclidemstat in Aggressive Ovarian Cancer Striking Young Women
July 13, 2020 3:00 pmA drug known as SP-2577 could help enable the body’s own immune system to attack ovarian cancer, according to a study led by the Translational Genomics Research Institute (TGen), an affiliate of City of Hope.
Published today in the scientific … Read more